Impact of Implementation of a Region-Wide Low-Density Lipoprotein Cholesterol Management Clinical Pathway for the Secondary Prevention of Acute Myocardial Infarction
Implementation of a region-wide clinical pathway for LDL-C management significantly improved the rate of intensive lipid-lowering therapy and the achievement of LDL-C targets.
Authors
- Kazuma Iekushi (ORCID: https://orcid.org/0000-0002-8056-4281)
- T Yamaguchi
- Shinsuke Muto
- Daisuke Yarimizu (ORCID: https://orcid.org/0000-0003-4547-2805)
- Takashi Fujii
- Satoshi Ikeda (ORCID: https://orcid.org/0000-0001-5203-7911)
- Yuji Koide (ORCID: https://orcid.org/0000-0001-8154-7187)
- Shinnosuke Furudono
- Tatsuya Nunohiro
- Mitsutoshi Toda
- Katsuaki Sakai (ORCID: https://orcid.org/0000-0002-8118-3448)
- Masaya Kurobe
- Kensho Baba
- Tomoo Nakata
- Masahiko Ishizaki
- M. Hazama
- Koji Maemura
Institutions
- Novartis (Switzerland) (CH)
- Japanese Red Cross Society, Japan (JP)
- Fujimoto Dental and Oral Surgery Clinic (JP)
- Nagasaki Ajisai Hospital (JP)
- Bay Medical Center (US)
- Midorigaoka Hospital (JP)
- Nagasaki University Hospital (JP)
- Sendai Kousei Hospital (JP)
- Nagasaki University (JP)
Publication Details
- Journal
- Circulation Journal
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1253/circj.cj-24-0338
- Citations
- 15
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 8.59
Funders
- Novartis Pharma